Izumi Tatsuo

Avg. Two Year Performance

1% Avg. Purchase Return
1% Compound
(65%) Avg. Sale Return
(29%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(15%)(< 1%)(1%)55%1%
Purchase Success Rate1 of 21 of 20 of 22 of 21 of 2
Average Sale Return(< 1%)(5%)6%(71%)(65%)
Sale Success Rate0 of 10 of 11 of 10 of 10 of 1

MediciNova Inc.

Drugs » Biotechnology

Director:

Holdings: 758.73K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--